METHOD FOR PREPARING 4-[17.BETA.-METHOXY-17.ALPHA.-METHOXYMETHYL-3-OXOESTRA-4,9-DIEN-11.BETA.-YL]BENZALDEHYDE (E)-OXIME (ASOPRISNIL)

The present invention relates to a method for the reliable and reproducible preparation of 4-[17.beta.-methoxy-17.alpha.-methoxymethyl-3-oxoestra-4,9-dien-ll.beta.- yl]benzaldehyde (E)-oxime (asoprisnil) on the pilot and manufacturing scale. Asoprisnil, which is prepared by this method, is distingui...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: VOIGTLAENDER, DAVID, MOSEBACH, MICHAEL, GERECKE, HAGEN, EILERS, ROBERT, KNABE, UWE, TILSTAM, ULF, JACKE, JUERGEN, GLIESING, SABINE, WEHMEIER, DIETER, BOHLMANN, ULF, MUELLER, UWE, HOESEL, PETER, MICHEL, THOMAS, BAHL, KLAUS, SANDER, MICHAEL, GRAWE, DETLEF, ERHART, BERND
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to a method for the reliable and reproducible preparation of 4-[17.beta.-methoxy-17.alpha.-methoxymethyl-3-oxoestra-4,9-dien-ll.beta.- yl]benzaldehyde (E)-oxime (asoprisnil) on the pilot and manufacturing scale. Asoprisnil, which is prepared by this method, is distinguished by a very good physical stability and is therefore particularly suitable for the manufacture of solid pharmaceutical forms (tablets, coated tablets, etc.). L'invention porte sur une méthode de préparation de 4-[17.beta.-methoxy-17.alpha.-méthoxyméthyl-3-oxoestra-4,9-dien-11.beta.-yl]benzaldéhyde (e)-oxime (asoprisnil) à l'échelle pilote et à l'échelle de fabrication. L'asoprisnil, préparé par cette méthode, qui se distingue par une très bonne stabilité physique, est donc particulièrement adapté à la fabrication de formes pharmaceutiques solides (comprimés, comprimés pelliculés, etc.).